Filed: 2/13/2025ACC: 0001395064-25-000028
📋 What this filing means
TAKEDA PHARMACEUTICAL CO LTD filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $232.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$232.31M
Total AUM (reported)
28.61M
Total Shares
Allocation by class
COM$223.95M96.4%
SHS$6.72M2.9%
COM CL A$817.7K0.4%
COM CL A NEW$505.3K0.2%
COMMON STOCK$321.4K0.1%
Portfolio Concentration
Top 3$211.13M90.9%
4–10$20.33M8.7%
11–25$855.9K0.4%
Top 3 weight
90.9%
Top 10 weight
99.6%
Voting Authority Distribution
Total shares with voting rights: 28.61M
Sole
Full voting authority
28.61M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other11
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
Denali Therapeutics Inc.
SOLEShares4.21M
TypeSH
Market value$97.86M
42.13%
Sole
4.21M
Shared
0.00
None
0.00
HilleVax, Inc.
DFNDShares6.72M
TypeSH
Market value$97.23M
41.85%
Sole
6.72M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares1.56M
TypeSH
Market value$16.04M
6.90%
Sole
1.56M
Shared
0.00
None
0.00
Wave Life Sciences Ltd.
DFNDShares1.35M
TypeSH
Market value$6.72M
2.89%
Sole
1.35M
Shared
0.00
None
0.00
Ovid Therapeutics Inc.
DFNDShares7.53M
TypeSH
Market value$5.79M
2.49%
Sole
7.53M
Shared
0.00
None
0.00
Turnstone Biologics Corp.
DFNDShares895.82K
TypeSH
Market value$2.35M
1.01%
Sole
895.82K
Shared
0.00
None
0.00
Shattuck Labs, Inc.
DFNDShares515.62K
TypeSH
Market value$1.99M
0.86%
Sole
515.62K
Shared
0.00
None
0.00
Xilio Therapeutics, Inc.
DFNDShares1.48M
TypeSH
Market value$1.40M
0.60%
Sole
1.48M
Shared
0.00
None
0.00
Equillium, Inc.
DFNDShares1.82M
TypeSH
Market value$1.26M
0.54%
Sole
1.82M
Shared
0.00
None
0.00
Rani Therapeutics Holdings, Inc.
DFNDShares215.17K
TypeSH
Market value$817.7K
0.35%
Sole
215.17K
Shared
0.00
None
0.00
American Well Corp
DFNDShares1.55M
TypeSH
Market value$505.3K
0.22%
Sole
1.55M
Shared
0.00
None
0.00
Akili, Inc.
DFNDShares738.82K
TypeSH
Market value$321.4K
0.14%
Sole
738.82K
Shared
0.00
None
0.00
STANDARD BIOTOOLS INC.
DFNDShares16.52K
TypeSH
Market value$29.2K
0.01%
Sole
16.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc.SOLE | COM | 4.21M | SH | $97.86M 42.13% | 4.21M | 0.00 | 0.00 |
HilleVax, Inc.DFND | COM | 6.72M | SH | $97.23M 41.85% | 6.72M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 1.56M | SH | $16.04M 6.90% | 1.56M | 0.00 | 0.00 |
Wave Life Sciences Ltd.DFND | SHS | 1.35M | SH | $6.72M 2.89% | 1.35M | 0.00 | 0.00 |
Ovid Therapeutics Inc.DFND | COM | 7.53M | SH | $5.79M 2.49% | 7.53M | 0.00 | 0.00 |
Turnstone Biologics Corp.DFND | COM | 895.82K | SH | $2.35M 1.01% | 895.82K | 0.00 | 0.00 |
Shattuck Labs, Inc.DFND | COM | 515.62K | SH | $1.99M 0.86% | 515.62K | 0.00 | 0.00 |
Xilio Therapeutics, Inc.DFND | COM | 1.48M | SH | $1.40M 0.60% | 1.48M | 0.00 | 0.00 |
Equillium, Inc.DFND | COM | 1.82M | SH | $1.26M 0.54% | 1.82M | 0.00 | 0.00 |
Rani Therapeutics Holdings, Inc.DFND | COM CL A | 215.17K | SH | $817.7K 0.35% | 215.17K | 0.00 | 0.00 |
American Well CorpDFND | COM CL A NEW | 1.55M | SH | $505.3K 0.22% | 1.55M | 0.00 | 0.00 |
Akili, Inc.DFND | COMMON STOCK | 738.82K | SH | $321.4K 0.14% | 738.82K | 0.00 | 0.00 |
STANDARD BIOTOOLS INC.DFND | COM | 16.52K | SH | $29.2K 0.01% | 16.52K | 0.00 | 0.00 |